GAD2 and type 1 diabetes mellitus: GADA to N-terminally truncated (amino acids 96-585 (42) or 143-585 (43)) GAD65 (t-GADA) were found to be of higher disease prediction than GADA to full-length GAD65 in preclinical cohorts of first-degree relatives without the loss of sensitivity in T1D patients (44).